Marco De Bruyn - Gynecology

Author Information

M. de Bruyn is affiliated with the Department of Obstetrics and Gynecology at the University Medical Center Groningen, University of Groningen, Groningen, the Netherlands. This information is sourced from PubMed.

Research Contributions

M. de Bruyn has made significant contributions to the field of gynecologic oncology, particularly focusing on endometrial and ovarian cancers. The research encompasses various aspects including the role of tertiary lymphoid structures in prognosis, the identification and role of specific T cell subsets in cancer, and the development of cancer vaccines. The work also includes studies on chromosomal instability in cancer and the implementation of translational research findings into clinical trials. The author has published multiple papers in reputable journals, demonstrating a strong commitment to advancing knowledge and treatment options in gynecologic oncology.

Aliases

M. de Bruyn is also known by the following aliases: M De Bruyn, M. De Bruyn, and Marco De Bruyn.

Publication and Citation Metrics

Metric	Value
Total Citation Count	2785
H-index	28
Paper Count	70

Publications:

Tertiary lymphoid structures critical for prognosis in endometrial cancer patients

DOI: 10.1038/s41467-022-29040-x

Year: 2022

Expression of CD39 Identifies Activated Intratumoral CD8+ T Cells in Mismatch Repair Deficient Endometrial Cancer

DOI: 10.3390/cancers14081924

Year: 2022

Cancer tolerance to chromosomal instability is driven by Stat1 inactivation in vivo

DOI: 10.1101/2021.12.03.471107

Year: 2021

Prognostic image-based quantification of CD8CD103 T cell subsets in high-grade serous ovarian cancer patients

DOI: 10.1080/2162402X.2021.1935104

Year: 2021

CD20 positive CD8 T cells are a unique and transcriptionally-distinct subset of T cells with distinct transmigration properties

DOI: 10.1038/s41598-021-00007-0

Year: 2021

708 Preclinical studies support therapeutic application of the leukaemic cell-based cancer relapse vaccine DCP-001 in ovarian cancer

DOI: 10.1136/ijgc-2021-esgo.449

Year: 2021

Combined STING levels and CD103+ T cell infiltration have significant prognostic implications for patients with cervical cancer

DOI: 10.1080/2162402X.2021.1936391

Year: 2021

Rapid and efficient generation of antigen-specific isogenic T cells from cryopreserved blood samples

DOI: 10.1101/2021.11.12.468355

Year: 2021

595 Implementation of collaborative translational research (TransPORTEC) findings in an international endometrial cancer clinical trials program (RAINBO)

DOI: 10.1136/ijgc-2021-esgo.171

Year: 2021

263 Prognostic image-based quantification of CD8CD103 T cell subsets in high-grade serous ovarian cancer patients

DOI: 10.1136/ijgc-2021-esgo.370

Year: 2021

What Are the Exceptions?

What Causes Acquired Anatomical Abnormalities?

What is the Role of Neonatal Intensive Care Units (NICUs)?

Can Vitamin E Oil Aid in Postpartum Recovery?

What are Culture Tests?

What is an Advocate in Gynecology?

How Does Spinach Impact Heart Health?

What Challenges Might Trainees Face?

What is Tamoxifen?

How are Digital Spreadsheets Used in Gynecology?

Partnered Content Networks

Relevant Topics